Clinical data demonstrated that β-CTX, a marker reflecting OC activity, was markedly elevated in MBD patients (Table S1) and exhibited a negative correlation with the serum butyric acid level and fecal butyrate producers abundance (Figures 6D and S6H,I). This evidence concerns the gene CYP27A1 and Marchiafava-Bignami disease.